These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25244930)

  • 1. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.
    Fleming I
    Pharmacol Rev; 2014 Oct; 66(4):1106-40. PubMed ID: 25244930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytochrome P450 pathway in angiogenesis and endothelial cell biology.
    Fleming I
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):541-55. PubMed ID: 22009065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
    Fleming I
    Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular cytochrome p450 enzymes: physiology and pathophysiology.
    Fleming I
    Trends Cardiovasc Med; 2008 Jan; 18(1):20-5. PubMed ID: 18206805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
    Frömel T; Hu J; Fleming I
    Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450-dependent eicosanoid production and crosstalk.
    Fleming I
    Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
    Dos Santos LRB; Fleming I
    Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
    DuTeaux SB; Newman JW; Morisseau C; Fairbairn EA; Jelks K; Hammock BD; Miller MG
    Toxicol Sci; 2004 Apr; 78(2):187-95. PubMed ID: 14737000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel metabolic pathways for linoleic and arachidonic acid metabolism.
    Moghaddam M; Motoba K; Borhan B; Pinot F; Hammock BD
    Biochim Biophys Acta; 1996 Aug; 1290(3):327-39. PubMed ID: 8765137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
    Zordoky BN; El-Kadi AO
    Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
    Spector AA; Kim HY
    Biochim Biophys Acta; 2015 Apr; 1851(4):356-65. PubMed ID: 25093613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
    Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
    Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
    Pickens CA; Sordillo LM; Zhang C; Fenton JI
    Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
    Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
    Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
    Frömel T; Fleming I
    Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.